Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Accumulated Expenses (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Accumulated Expenses for 6 consecutive years, with $7957.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 32.77% to $7957.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7957.0 through Dec 2025, up 32.77% year-over-year, with the annual reading at $7957.0 for FY2025, 32.77% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $7957.0 at BioScience Health Innovations, up from $6686.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $24500.0 in Q2 2025, with the low at $450.0 in Q3 2021.
  • Average Accumulated Expenses over 5 years is $5810.1, with a median of $2000.0 recorded in 2024.
  • The sharpest move saw Accumulated Expenses crashed 91.0% in 2021, then skyrocketed 1125.0% in 2025.
  • Over 5 years, Accumulated Expenses stood at $450.0 in 2021, then changed by 0.0% to $450.0 in 2022, then soared by 222.22% to $1450.0 in 2023, then surged by 313.31% to $5993.0 in 2024, then soared by 32.77% to $7957.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $7957.0, $6686.0, and $24500.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.